Allison AC, Almquist SJ, Muller CD, Eugui EM (1991) In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 23:10–14
CAS
PubMed
Google Scholar
Allison AC, Eugui EM (1993) The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 14:353–380. https://doi.org/10.1007/BF00192309
Article
CAS
PubMed
Google Scholar
Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85–118. https://doi.org/10.1016/s0162-3109(00)00188-0
Article
CAS
PubMed
Google Scholar
Allison AC, Hovi T, Watts RW, Webster AD (1975) Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet 2:1179–1183. https://doi.org/10.1016/s0140-6736(75)92661-6
Article
CAS
PubMed
Google Scholar
Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S et al (2019) Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG. Cancer Cell 36(528–44):e10. https://doi.org/10.1016/j.ccell.2019.09.005
Article
CAS
Google Scholar
Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD et al (2012) An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol 108:29–35. https://doi.org/10.1007/s11060-011-0796-x
Article
PubMed
Google Scholar
Barfeld SJ, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi KM et al (2015) Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer. Oncotarget 6:12587–12602. https://doi.org/10.18632/oncotarget.3494
Article
PubMed
PubMed Central
Google Scholar
Barsotti C, Pesi R, Giannecchini M, Ipata PL (2005) Evidence for the involvement of cytosolic 5′-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine. J Biol Chem 280:13465–13469. https://doi.org/10.1074/jbc.M413347200
Article
CAS
PubMed
Google Scholar
Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M et al (2013) PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One 8:e77639. https://doi.org/10.1371/journal.pone.0077639
Article
CAS
PubMed
PubMed Central
Google Scholar
Benjanuwattra J, Chaiyawat P, Pruksakorn D, Koonrungsesomboon N (2020) Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent. Eur J Pharmacol 887:173580. https://doi.org/10.1016/j.ejphar.2020.173580
Article
CAS
PubMed
Google Scholar
Carr SF, Papp E, Wu JC, Natsumeda Y (1993) Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 268:27286–27290
Article
CAS
Google Scholar
Chen B, Ma L, Paik H, Sirota M, Wei W, Chua MS et al (2017) Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat Commun 8:16022. https://doi.org/10.1038/ncomms16022
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen B, Wei W, Ma L, Yang B, Gill RM, Chua MS et al (2017) Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology 152:2022–2036. https://doi.org/10.1053/j.gastro.2017.02.039
Article
CAS
PubMed
Google Scholar
Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV et al (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14:128. https://doi.org/10.1186/1471-2105-14-128
Article
Google Scholar
Chen Y, Sun L, Xu H, Dong M, Mizuno T, Vinks AA et al (2020) PK/PD Study of mycophenolate mofetil in children with systemic lupus erythematosus to inform model-based precision dosing. Front Pharmacol 11:605060. https://doi.org/10.3389/fphar.2020.605060
Article
CAS
PubMed
PubMed Central
Google Scholar
Chong YC, Toh TB, Chan Z, Lin QXX, Thng DKH, Hooi L et al (2020) Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression. Hepatol Commun 4:1362–1381. https://doi.org/10.1002/hep4.1559
Article
CAS
PubMed
PubMed Central
Google Scholar
Cohen KJ, Jabado N, Grill J (2017) Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol 19:1025–1034. https://doi.org/10.1093/neuonc/nox021
Article
CAS
PubMed
PubMed Central
Google Scholar
Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE et al (2017) The drug repurposing hub: a next-generation drug library and information resource. Nat Med 23:405–408. https://doi.org/10.1038/nm.4306
Article
CAS
PubMed
PubMed Central
Google Scholar
DeWire M, Fuller C, Hummel TR, Chow LML, Salloum R, de Blank P et al (2020) A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). J Neurooncol 149:511–522. https://doi.org/10.1007/s11060-020-03641-2
Article
CAS
PubMed
Google Scholar
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635
Article
CAS
PubMed
Google Scholar
Downing HJ, Pirmohamed M, Beresford MW, Smyth RL (2013) Paediatric use of mycophenolate mofetil. Br J Clin Pharmacol 75:45–59. https://doi.org/10.1111/j.1365-2125.2012.04305.x
Article
CAS
PubMed
Google Scholar
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND et al (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331–335. https://doi.org/10.1126/science.aao4750
Article
CAS
PubMed
PubMed Central
Google Scholar
Gaffo AL (2014) Crystal diseases. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease. Academic Press, San Diego, pp 251–306
Google Scholar
Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Soloski MJ et al (2010) Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl Immunol 23:45–52. https://doi.org/10.1016/j.trim.2010.04.002
Article
CAS
PubMed
PubMed Central
Google Scholar
Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21:555–559. https://doi.org/10.1038/nm.3855
Article
CAS
PubMed
PubMed Central
Google Scholar
Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394–1396. https://doi.org/10.1038/nm.3716
Article
CAS
PubMed
PubMed Central
Google Scholar
Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the international and european society for pediatric oncology DIPG registries. J Clin Oncol 36:1963–1972. https://doi.org/10.1200/JCO.2017.75.9308
Article
CAS
PubMed
PubMed Central
Google Scholar
Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A et al (2019) Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma. Clin Cancer Res 25:5572–5583. https://doi.org/10.1158/1078-0432.Ccr-18-3890
Article
CAS
PubMed
PubMed Central
Google Scholar
Katagi H, Takata N, Aoi Y, Zhang Y, Rendleman EJ, Blyth GT et al (2021) Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma. Neuro Oncol 23:1348–1359. https://doi.org/10.1093/neuonc/noab009
Article
CAS
PubMed
PubMed Central
Google Scholar
Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439–447. https://doi.org/10.1007/s00401-012-0998-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O et al (2019) IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nat Cell Biol 21:1003–1014. https://doi.org/10.1038/s41556-019-0363-9
Article
CAS
PubMed
PubMed Central
Google Scholar
Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform 12:323. https://doi.org/10.1186/1471-2105-12-323
Article
CAS
Google Scholar
Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S et al (2019) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaw0064
Article
PubMed
PubMed Central
Google Scholar
Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(520–37):e5. https://doi.org/10.1016/j.ccell.2017.08.017
Article
CAS
Google Scholar
Misek SA, Newbury PA, Chekalin E, Paithankar S, Doseff AI, Chen B et al (2022) Ibrutinib blocks YAP1 activation and reverses BRAF inhibitor resistance in melanoma cells. Mol Pharmacol 101:1–12. https://doi.org/10.1124/molpharm.121.000331
Article
CAS
PubMed
Google Scholar
Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B et al (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31:3971–3979. https://doi.org/10.1200/JCO.2013.50.4910
Article
CAS
PubMed
PubMed Central
Google Scholar
Pathania M, De Jay N, Maestro N, Harutyunyan AS, Nitarska J, Pahlavan P et al (2017) H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas. Cancer Cell 32:684-700 e9. https://doi.org/10.1016/j.ccell.2017.09.014
Article
CAS
PubMed
PubMed Central
Google Scholar
Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG et al (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999–4006. https://doi.org/10.1200/jco.2011.35.5677
Article
CAS
PubMed
PubMed Central
Google Scholar
Pessetto ZY, Chen B, Alturkmani H, Hyter S, Flynn CA, Baltezor M et al (2017) In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. Oncotarget 8:4079–4095
Article
Google Scholar
Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA et al (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23:493–500. https://doi.org/10.1038/nm.4296
Article
CAS
PubMed
PubMed Central
Google Scholar
Pollack IF, Agnihotri S, Broniscer A (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23:261–273. https://doi.org/10.3171/2018.10.Peds18377
Article
PubMed
PubMed Central
Google Scholar
Qin Y, Zheng X, Gao W, Wang B, Wu Y (2021) Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma. Mol Ther Oncolytics 20:342–351. https://doi.org/10.1016/j.omto.2021.01.011
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramaswamy V, Remke M, Taylor MD (2014) An epigenetic therapy for diffuse intrinsic pontine gliomas. Nat Med 20:1378–1379. https://doi.org/10.1038/nm.3769
Article
CAS
PubMed
Google Scholar
Risso D, Ngai J, Speed TP, Dudoit S (2014) Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol 32:896–902. https://doi.org/10.1038/nbt.2931
Article
CAS
PubMed
PubMed Central
Google Scholar
Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139–140. https://doi.org/10.1093/bioinformatics/btp616
Article
CAS
PubMed
Google Scholar
Rodríguez-Pascual J, Sha P, García-García E, Rajeshkumar NV, De Vicente E, Quijano Y et al (2013) A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Invest New Drugs 31:14–19. https://doi.org/10.1007/s10637-012-9822-x
Article
CAS
PubMed
Google Scholar
Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B et al (2014) Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol 127:881–895. https://doi.org/10.1007/s00401-013-1218-2
Article
CAS
PubMed
Google Scholar
Sasaki T, Katagi H, Goldman S, Becher OJ, Hashizume R (2020) Convection-enhanced delivery of enhancer of zeste homolog-2 (EZH2) inhibitor for the treatment of diffuse intrinsic pontine glioma. Neurosurgery 87:E680–E688. https://doi.org/10.1093/neuros/nyaa301
Article
PubMed
PubMed Central
Google Scholar
Schmidt F, Rieger J, Wischhusen J, Naumann U, Weller M (2001) Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage. Eur J Pharmacol 412:21–25. https://doi.org/10.1016/s0014-2999(00)00923-7
Article
CAS
PubMed
Google Scholar
Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231. https://doi.org/10.1038/nature10833
Article
CAS
PubMed
Google Scholar
Serwer L, Hashizume R, Ozawa T, James CD (2010) Systemic and local drug delivery for treating diseases of the central nervous system in rodent models. J Vis Exp. https://doi.org/10.3791/1992
Article
PubMed
PubMed Central
Google Scholar
Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH et al (2021) De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain 144:1230–1246. https://doi.org/10.1093/brain/awab020
Article
PubMed
PubMed Central
Google Scholar
Stone TW, Simmonds HA (1991) Metabolism of endogenous purines. In: Purines: basic and clinical aspects. Springer Netherlands, Dordrecht, pp 251–306. https://doi.org/10.1007/978-94-011-3911-3
Chapter
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. https://doi.org/10.1073/pnas.0506580102
Article
CAS
PubMed
PubMed Central
Google Scholar
Takebe N, Cheng X, Fandy TE, Srivastava RK, Wu S, Shankar S et al (2006) IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol Cancer Ther 5:457–466. https://doi.org/10.1158/1535-7163.Mct-05-0340
Article
CAS
PubMed
Google Scholar
Taubes A, Nova P, Zalocusky KA, Kosti I, Bicak M, Zilberter MY et al (2021) Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease. Nat Aging 1:932–947. https://doi.org/10.1038/s43587-021-00122-7
Article
PubMed
PubMed Central
Google Scholar
Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140:1–22. https://doi.org/10.1007/bf00928361
Article
CAS
PubMed
Google Scholar
Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A et al (2017) Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol 35:314–316. https://doi.org/10.1038/nbt.3772
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Q, Guan YF, Hancock SE, Wahi K, van Geldermalsen M, Zhang BK et al (2021) Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth. J Pathol 254:135–146. https://doi.org/10.1002/path.5665
Article
CAS
PubMed
Google Scholar
Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251–253. https://doi.org/10.1038/ng.1102
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444–450. https://doi.org/10.1038/ng.2938
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu J, Jaar BG, Briggs WA, Choi MJ, Kraus ES, Racusen LC et al (2004) High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: a case series. Nephron Clin Pract 98:c61–c66. https://doi.org/10.1159/000080674
Article
PubMed
Google Scholar
Zeng B, Glicksberg BS, Newbury P, Chekalin E, Xing J, Liu K et al (2021) OCTAD: an open workspace for virtually screening therapeutics targeting precise cancer patient groups using gene expression features. Nat Protoc 16:728–753. https://doi.org/10.1038/s41596-020-00430-z
Article
CAS
PubMed
Google Scholar
Zeng WZD, Glicksberg BS, Li Y, Chen B (2019) Selecting precise reference normal tissue samples for cancer research using a deep learning approach. BMC Med Genomics 12:21. https://doi.org/10.1186/s12920-018-0463-6
Article
PubMed
PubMed Central
Google Scholar
Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK et al (2020) Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun 11:3811. https://doi.org/10.1038/s41467-020-17512-x
Article
CAS
PubMed
PubMed Central
Google Scholar